Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

4.85
+0.15003.19%
Post-market: 4.940.0900+1.86%19:59 EDT
Volume:119.48K
Turnover:579.95K
Market Cap:13.86M
PE:-0.21
High:4.99
Open:4.70
Low:4.70
Close:4.70
Loading ...
May 10, 2021

Major Issues Report

8-K - Current report
May 03, 2021

Major Issues Report

8-K - Current report
Apr 30, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 27, 2021

Major Issues Report

8-K - Current report
Apr 16, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Mar 11, 2021

Major Issues Report

8-K - Current report
Mar 09, 2021

Major Issues Report

8-K - Current report
Mar 05, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Major Issues Report

8-K - Current report
Jan 28, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 27, 2021

Major Issues Report

8-K - Current report